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Introduction
Mammalian growth plate, also known as epiphyseal
plate or physis, is highly specialized mesoderm-
derived cartilaginous structure. It develops in the bone
bud, secondary to presence of the primary ossification
centers and is responsible for bone elongation. The
plates are formed by numerous cells that rapidly divide
and mature. Post puberty, the epiphyseal cartilage cell
division decreases, bone completely replaces cartilage,
and the epiphyseal plates fuse together with primary and
secondary ossification centers [1,2].
Cartilage differentiation process
Presently, four major stages of chondrocyte differenti-
ation are known, i.a., mesenchymal precursor cells
(MPCs), prechondrocytes, early chondroblasts and ter-
minally differentiated chondrocytes [1-4].
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Abstract: The epiphyseal growth plate develops from the cartilaginous-orientated mesenchymal cells that express SOX
family genes. This multilayer structure is formed by the proliferation and hypertrophy of cells that synthesize the extracel-
lular matrix composed of collagen (mainly type II, IX, X, XI) and proteoglycans (aggrecan, decorin, annexin II, V and VI).
The resting zone is responsible for protein synthesis and maintaining a germinal structure. In the proliferative zone, cells
rapidly duplicate. The subsequent morphological changes take place in the transformation zone, divided into the upper and
lower hypertrophic layers. In the degenerative zone, the mineralization process becomes intensive due to increased release
of alkaline phosphate, calcium and matrix vesicles by terminally differentiated chondrocytes and some other factors e.g.,
metaphyseal ingrowth vessels. At this level, as well as in the primary and secondary spongiosa zones, chondrocytes under-
go apoptosis and are physiologically eliminated. Unlike adult cartilage, in fetal and early formed growth plates, unusual
forms such as autophagal bodies, paralysis and dark chondrocytes are also observed. Their ultrastructure differs greatly from
apoptotic and normal cartilage cells. Chondrocyte proliferation and differentiation are regulated by various endocrine,
paracrine, and autocrine agents such as growth, thyroid and sex hormones, beta-catenin, bone morphogenetic proteins,
insulin-like growth factor, iodothyronine deiodinase, leptin, nitric oxide, transforming growth factor beta and vitamin D
metabolites. However, the most significant factor is parathyroid hormone-related protein (PTHrP) which is synthesized in
the perichondrium by terminally differentiated chondrocytes. Secondary to activation of PTH/PTHrP receptors, PTHrP
stimulates cell proliferation by G protein activation and delays their transformation into prehypertrophic and hypertrophic
chondrocytes. When proliferation is completed, chondrocytes release Indian hedgehog (Ihh), which stimulates PTHrP syn-
thesis via a feedback loop. Any disturbances of the epiphyseal development and its physiology result in various skeletal
abnormalities known as dysplasia.
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The initial steps in cartilage formation are second-
ary to condensation of mesenchymal cell from 12 to 15
per 1000 μm2. MPCs initiate chondrogenesis by first
migration to presumptive skeletogenic sites from the
cranial neural crest, paraxial mesoderm, and lateral
plate mesoderm and formation of cell mass condensa-
tions [3,5]. MPCs divide in the center of the condensa-
tions to form prechondrocytes that turn off the expres-
sion of mesenchymal and condensation markers.
Instead of an elongated shape they become rounder
with concomitant decrease of intercellular adhesion
and intensive endothelial cell proliferation [6]. Such
process is highly dependent on N-catherin and the
presence of glycosaminoglycans, which synthesis
stops at the end of cellular condensation [7]. Mes-
enchymal-endothelial junctions are stabilized by
fibronectin, the synthesis of which is stimulated by
transforming growth factor β (TGFβ) [8]. The follow-
ing steps depend on syndecan-3 which requires trans-
formations from mesenchymal condensation to direct
skeleton development and prohibits the mesenchyme
over-proliferation [3,9]. Simultaneously, most of the
primary vessels disappear, and only those stimulated
by vascular endothelial growth factor (VEGF) persist
[5]. Secondary to transcriptional factor Runx2, mes-
enchymal cells commences synthesis of collagen type
I, osteocalcin, osteonectin and osteopontin. Such pri-
mary selected cells are characterized by high expres-
sion of gene coded bone morphogenetic protein 
6 (BMP6). In contrast, cells predominately directed to
cartilage development have high expression of Sox
family genes that regulate synthesis of collagen type II
and its isoform IIa1, as well as collagen IXa1 and XIa2
[3,10,11]. Sox9 plays a crucial role in the chondrogen-
esis initiation [12]. However, it was already proven
that due to unknown molecular mechanism, some cells
with Sox expression may develop to osteoprogenitor
cells [13]. Differentiation of prechondrocytes leads to
active chondrogenic cells called chondroblasts, which
rapidly proliferate and build new bone tissue. They
expressed Sox9 which is required for further differen-
tiation [14]. Sox9 is highly expressed in prechondro-
cytes and chondroblasts, however, once the cells
undergo prehypertrophy or hypertrophy, the gene turns
off [15]. In the study of Akiyama et al. [12] inactiva-
tion of Sox9 using Prx1Cre transgene, a gene
expressed in early limb bud mesenchymal cells, result-
ed in lack of appendicular cartilage elements in
embryo. Such observations have suggested that tran-
scription factors have been identified to control mes-
enchymal cell migration, proliferation, survival, and
condensation in one or a subset of cartilage elements.
These elements control the skeletal development in
multiple species and are also referred to as patterning
factors since they determine the shapes and sizes of the
skeletal elements [1,14].
Prechondrocyte differentiation leads to the next
stage, known as early chondroblasts. Early chondrob-
lasts develop cartilage growth plates by assuming 
a flattened shape and organizing into longitudinal
columns. They proliferate at a high rate until, one layer
at a time; they exit the cell cycle and start to increase
in size, undergoing prehypertrophy followed by full
hypertrophy. They undergo apoptosis to allow primary
ossification centers to expand. Cells located in the
middle of the epiphysis of future long bones undergo 
a similar maturation process that leads to the formation
of secondary ossification centers [1,2,16].
Chondrocytes are metabolically active cells that
synthesize various elements of the extracellular matrix
(ECM) [17] They are also a source of so called matrix
vesicles, 100 nm in diameter-follicles, formed by sep-
aration of cellular membrane [4,18,19]. The calcium
accumulation in matrix vesicles seems to be directly
related to calcium channel molecules – annexin II, V
and VI that are found in the external lipid bilayer of the
vesicles. Collagens type II and X bind to matrix vesi-
cles and, in turn, interact with the annexin V [20]. The
role of type X collagen, primarily found in the hyper-
trophic zone (see below), is to facilitate the deposition
of calcium within the matrix [21]. Some other matrix
elements are also involved in this process mostly pro-
teoglycans, e.g., aggrecan which aids in the osmotic
properties that are essential for resisting compressive
loads, as well as decorin that regulates collagen fibril-
logenesis. On the contrary, cartilage oligomeric pro-
tein is a non-collagenous calcium binding glycoprotein
found in the ECM [22].
Growth plate morphology and physiology
Each growth plate is a sandwich-like, multilayer struc-
ture divided into four well defined zones: reserve, pro-
liferative, transformation and degeneration (Fig. 1).
The last zone is adjusted to the primary spongiosa zone
that finally gives origin for the secondary spongiosa
zone.
Resting cartilage cells lying within the reserve zone
(also known as resting or germinal zone) are formed
by small, uniform, compactly located chondrocytes
that occur singly or in pairs and are rich in lipid and
cytoplasmic vacuoles (Fig. 2A). Additionally, in the
zone ECM take more place than cells [1]. This zone is
characterized also by low rates of proliferation and
proteoglycan and collagen type IIB synthesis [1,13]. It
is surrounded the groove of Ranvier, that hosts chon-
drocyte progenitor cells, which flow into the cartilage
of this germinal layer [1,22].
The direct continuation of the reserve zone is the
second layer known as proliferative zone. Its chondro-
cytes are flat and well divided into longitudinal
columns (Fig. 2B). The mitotic activity is found only
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in the base of the columns. This true germinal layer has
increased type II and type XI collagen synthesis [22].
Below the proliferative zone is another layer
known as transformation zone, divided into upper and
lower hypertrophic zone and a farther located degener-
ation zone. The most characteristic feature of chondro-
cytes of this level is lack of cellular division and
decreased DNA synthesis. Instead of proliferation the
cells synthesize high amount of various elements of
ECM. It is worth to mention that this is the only zone
that contains short-chain collagen and the first to pro-
duce alkaline phosphatase, responsible for the widen-
ing of the growth plate by increasing phosphate ions
that are required for calcification [1,2,22]. Compared
to the other zones chondrocytes of transformation one
are relatively larger. They begin to terminally differen-
tiate and become swollen (Fig. 2C and 2D). Closer to
the primary spongiosa zone the amount of cells with
features of degeneration increases. Chondrocytes lose
intercellular junctions and are located in special vesi-
cles formed by ECM [1].
Major phenotypic changes occur when chondrob-
lasts divide into prehypertrophic and hypertrophic
chondrocytes. Cytoplasmic volume increases ten times
and levels of mRNA increase for most early cartilage
matrix genes [14]. Once they reach the hypertrophic
stage, they no longer express early cartilage matrix
genes. Cells located centrally to the cartilage anlagen
differentiate directly to prehypertrophy from pre-
chondrytic or early chondroblastic stage [1,14,17].
This process is regulated by genes Sox5/Sox6. These
genes function is to hinder the prehypertrophy rate and
to promote hypertrophy [23].
Chondroblast columnar proliferation is also assist-
ed by a transcriptional activator of the Runt domain.
This domain holds the activator Runx2 which directs
organization of columns by influencing chondroblast
proliferation. Runx2 is expressed in chondrogenic
mesenchymal cells and hypertrophic and terminally
differentiated chondrocytes but is inactivated in chon-
droblasts [24]. Runx2 and Runx3 both induce chondro-
cyte prehypertrophy and hypertrophy. When Runx2
was expressed in chondroblasts of transgenic mice, the
cells showed ectopic maturation, however, when the
negative form was expressed in the same cells, events
of prehypertrophy followed [25]. Therefore, it seems
that Runx2 is a direct transcriptional activator of chon-
drocyte maturation markers.
The maturation of chondrocytes is due to physical
and biochemical changes that occur in a spatial and tem-
poral pattern. In differentiation, there is a 5-10-fold
increase in intracellular volume, which is not a passive
swelling. Instead, it is an active process by which there
is an increase in organelles such as mitochondria and the
endoplasmic reticulum [5,26]. The chondrocytes locat-
ed in bones with rapid growth such as the femur,
increase at a faster pace than chondrocytes in bones, like
the radius, primarily due to the proportions of size [27]. 
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Fig. 1. Longitudinal section of the prox-
imal femoral epiphysis from 21-day-old
rat pup (H+E, original magnification
×100).
Despite of above mentioned alkaline phosphate,
one of the most important factors for chondrocyte
hypertrophy and terminal differentiation is the tran-
scription core binding factor 1 (CBFA1) [25]. Howev-
er in mice lacking CBFA1 in their growth plate, nor-
mal hypertrophy is observed, which indicates that
other transcription factors like Smad-1, -5 and -8 also
play an important role in this process [25,28,29].
The morphology of the lowest zone – primary
spongiosa – is similar to the lower level of degenera-
tion zone. However, it is characterized by presence of
osteoprogenitor cells. Due to initiation of mineraliza-
tion process, primary ossified bone lamella and small
blood vessels are also visible [1,2,22].
As hypertrophy shifts to terminal differentiation,
the gene Col10a1 ceases to be expressed in chondro-
cytes leading to the activation of a new group of genes
[14]. They induce extracellular matrix mineralization
and as current view states, they result in cell death, or
apoptosis. The importance of a terminally differentiat-
ed chondrocyte seems to be the preparation of calcifi-
cation by the matrix; since once the cartilage calcifies,
apoptosis is required to remove the terminally differ-
entiated chondrocytes. After the cartilage has under-
gone calcification, the removal of differentiated chon-
drocytes allows for access by the vascular channels
and bone-marrow stromal cells [30-35]. Chondrocytes
in the hypertrophic zone have similar morphological
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Fig. 2. Chondrocytes of the reserve (A), proliferative (B), hypertrophic (C), and degenerative (D) zones of the proximal femoral epiph-
ysis from the 7-day-old rat pup (TEM, original magnification ×3000).
characteristic to other cells undergoing apoptosis such
as the condensation of the nuclear chromatin, cell
shrinkage, and plasma membrane blebbing [1,4,9,22].
It should be noted, that early growth plate – visible
before the secondary ossification centers are formed –
is an avascular structure which relies on receiving
nutrients and oxygen via diffusion from the vascular
arcades presented in the metaphyseal side of the epi-
physis [31]. The anatomical location of the vascular
channels is between the calcified cartilages under the
last row of hypertrophic chondrocytes [30]. VEGF is
the key factor responsible for vascular ingrowths,
which is physiologically expressed solely by the
hypertrophic chondrocytes [5,22].
Physiological chondrocytes elimination
Chondrocytes similar to most other mammalian cells
are physiologically eliminated via programmed cell
death. However, unlike in other greatly vascular tis-
sues, removal of apoptotic bodies is difficult due to
large amounts of ECM, and is only possible in the pri-
mary spongiosa zone [4,9,33,34].
Typically apoptotic cells are characterized by
nuclear chromatin condensed into dark crescents, caps,
spheres, and smaller so called shrinks size. Such
changes are secondary to DNA fragmentation and
intracellular disintegration. The cells and apoptotic
bodies are typical for adult cartilage; however, rapidly
undergo phagocytosis [36]. In fetal and early formed
growth plates, some other types like authophagal bod-
ies, paralysis and dark chondrocytes are also observed
(Table 1) [4,18,32].
Authophagal bodies
It was found that morphology of some hypertrophic
chondrocytes was diverse that of apoptic cells with
irregular nuclei and an exaggerated endoplasmic retic-
ulum [37]. These cells were unable to live or die anal-
ogous to a paralytic state, a form of cell death similar
to dark chondrocytes (see below). These cells under-
went autophagy [38,39] that is a process that involves
the cell using its own components to degrade itself by
lysosomes. These cells contain double-membrane
autophagic vacuoles, termed autophagosomes that are
used for self degradation. Autophagy protects the cells
by consuming its own lipids and nutrients to generate
energy when nutrients are deficient [40]. Protein Tor is
the main component involved in detection of nutrients
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Table 1. Basic morphological features in various types of programmed cell death of chondrocytes (based on Roach and Clarke [44] with
own modification).
concentration. It blocks autophagy when nutrients are
available [41,42]. A negative regulator of Tor protein is
AMP-dependent protein kinase associated with the
cell redox status, which blocks Tor complex.
Autophagy is also regulated by low oxygen and/or low
protein levels. Additionally, low glucose level signals
glycolysis which lowers ATP and use of nutrients, pro-
moting autophagy [42].
Paralysis chondrocytes
The paralysis chondrocytes develop secondarily to the
focal digestion of cytoplasm and organelles that occurs
within an internal "island" formed by an enlarged and
highly hydrated lumen of the endoplasmic reticulum
[43]. The next step in cellular disintegration is always
chromatin condensation with formation of typical
small patches throughout the nucleus that usually has 
a convoluted outline. Similar to other types of pro-
grammed cell death, and unlike necrosis, release of
proteolytic enzymes has not been observed. In the late
stages, formation of small, blister-like, vacuolated
structures from pseudopodias, which is presently
known as blebbing is observed. Elimination of paraly-
sis and dark chondrocytes are probably similar and
will be explained below [33,43,44].
Dark chondrocytes
In the last few decades numerous authors have report-
ed a presence of chondrocytes which have a different
morphology from so-called normal (light) cells in the
same growth plate zone. Due to their characteristic
images in transmission electron microscope (TEM)
they are known as dark chondrocytes (Fig. 3) [4,18].
Dark chondrocytes have different signs of degener-
ation, like the separation of a nucleolus "cap", single
blebs of plasmalemma, and are also seem to be more
viable. The typical nucleus of a dark cell includes the
tandemic arrangement of chromatin condensations,
large, compact, nucleolus, and undeveloped accessory
nucleoli. Contrary to them, light chondrocytes possess
evenly shaped nuclei with dispersed chromatin. As
dark cells become more advanced, the density of their
karyoplasms increases and condenses into chromone-
ma-like strands or irregular clumps (less often). Both
light and dark cells usually contain one or two central-
ly located nucleoli of differing types, the "compact
nucleolus". However, in more advanced dark cells, the
nucleoli appeared to be hyper-compacted and smaller,
suggesting degeneration. It is worth mentioning that
their nuclear membrane often contains defects. The
segments ravel into small inverted buds and dissolve
together with adjacent chromatic clumps to release
pore complexes [4,18,33,38].
It should be stressed that such cells have a particu-
lar path of division. They are not present in normal
mitosis, but only sandwich-like amitotic nuclear segre-
gation. Their nuclei commonly lose nucleoli and
hyper-compact, after which they dissolve. Additional-
ly, such cells have a chromatic arrangement similar to
that of condensed pro-metaphase or metaphase. These
lack nucleoli, but are surrounded to some extent by 
a nuclear membrane. Sometimes, microtubules are
located between lobes of chromatin clumps that
resemble chromosomes. This pattern has been identi-
fied in some tumor and irradiated cells and is known as
a "clover leaf" [38,45]. Similarly, the metaphase-like
chromatin figures in interphasic cells are also found on
cell imprints. All forms that look like division have
characteristics of aberrancy, i.a., minimal, to a lack of
spindle elements, maintain nuclear membrane, hyper-
compaction and chromatin dissolution [38,46].
Unlike light chondrocytes that have small mito-
chondria and sparse rosettes of glycogen, dark cells are
characterized by plenty of glycogen and large swollen
mitochondria with well developed cristae, which occa-
sionally possess fenestrae and dark matrix. The Golgi
complex is the dominant organelle. At times, even the
nucleus appears as an enlarged "belly" of the Golgi. In
some locations, it appears as if the entire cisternae are
destined to rupture or protrude to the exterior of the
cell. Besides, multiple invaginations of the ground
cytoplasm in the dilated cisternae are found. Such cells
contain also ribosomes and form "inverted channels".
The cell membrane blebbing (zeiosis) is also typical of
dark cells and less often the cytoplasm is disintegrated.
Such membrane fragmentation gives origin to the
above mentioned matrix vesicles [18,38,46].
It should be noted that there are also nuances in
dark cells during their transitional phase. Cells which
appear to be transitory are observed only in early
embryos. Arguably these cells could be transitioning,
just as likely, from dark to light chondrocytes. These
cells have two distinct characteristics of dark cells-pat-
tern of chromatic compactions and "inverted" mem-
brane, but their karyoplasm and ground cytoplasm are
not condensed [4,18,38].
Dark cells also exhibit atypical characteristics during
cell death. At times, these small dark cells resemble
apoptotic ones, however, they do not have typical con-
densed chromatin. There were two different degenera-
tion patterns: one where the karyolitic dark cell forms 
a pair with a normal chondrocyte in the proliferating
zone, and in the resting zone, the karyopycnotic dark cell
is engulfed by a light chondrocyte. The generally accept-
ed hypothesis states that elimination of dark cells or their
remnants occurs in the lower primary spongiosa zone
due to phagocytosis. However, in the upper part of the
growth plate, the cell size reduces and their matrix lacu-
na becomes smaller secondary to a higher secretion of
ECM elements and the release of matrix vesicles. This
explains the high number of empty lacunas observed in
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various developmental studies. The second mechanism
seems to be prominent in the proliferative zone, where
the cell space is taken up by the expansion of the ECM
around neighboring chondrocytes [4,43,46].
Until now, dark chondrocytes were reported only in
human fetal cartilage [46], mice mandibular condyle
[48], physes of piglets [49], proximal epiphyses of the
femur and humerus in young (0-9 day, and 5- and 20
weeks old) New Zealand rabbits [33], proximal
femoral growth plate of 14-15 day chick embryos 
[4, 38], as well as 21-day old fetuses [18] and 7-day
old pups of Wistar rats [50]. Dark chondrocytes were
present in about 10-35% of avian embryos growth
plates and were found in all stages of chondrocyte dif-
ferentiation and in all ages of studied femurs. In every
zone, such cells were revealed to be juxtaposed to light
ones. They were even observed in mineralized areas
with signs of degeneration, and found to be abundant
in proliferating cells. Sporadically, they were even
seen sharing a common lacuna [4,38]. Unlike those
findings, such dark cells were present only occasional-
ly in rat offsprings [18]. Among the six proximal epi-
physes of the fetal femur, they were found only in four
separate specimens. The prenatal fetuses exposed to
various cyclooxygenase inhibitors, possessed dark
chondrocytes in 23 out of the 32 examined samples,
without any association with administered drugs. Sim-
ilar frequency and the same localization of dark cells,
limited to the germinal and proliferative zones, were
later reported by Solecki [50]. The last two cited
reports are the only fully available ones that presents
such chondrocytes in animals exposed to xenobiotics.
Regulation of differentiation
There are two main mechanisms that eliminate hyper-
trophic cells. One mechanism is apoptosis, where ter-
minally differentiated cells die. The second mecha-
nism is transdifferentation, where mature chondro-
cytes are removed by converting them into bone form-
ing cells or osteoblasts [22]. The latter mechanism
allows the cells to undergo a drastic change in pheno-
type and new genes to be expressed [33,34].
On the other hand, there are several molecular, bio-
chemical, as well as morphological changes that take
place during differentiation. The growth of bones
depends solely on the proliferation and hypertrophy of
the chondrocytes located within the growth plate. Apop-
tosis is also crucial for the terminal chondrocyte matura-
tion, which relies on the secretion of matrix. This process
assists in the matrix calcification and is regulated by
interactions with various hormones, peptides, and
growth factors, which are synthesized locally [33-35].
The key enzymes in apoptosis initiation are caspas-
es, which belong to the cysteine protease family. Cas-
pases are found in the cytoplasm of all cells in the
inactive form awaiting a primer to activate apoptosis
[22,35]. In vitro experiments have shown that chon-
drocytes with high phosphate concentrations exhibit
an increased apoptotic activity [51]. This phenomenon
is more common in differentiated than in less differen-
tiated chondrocytes. This increase in phosphate is 
associated with abnormal mitochondrial function of
chondrocytes, which causes a greater reliance on gly-
colysis with progression towards hypertrophy [52]. 
11Epiphyseal growth plate
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(1): 11 (5-16) 
doi: 10.2478/v10042-009-0007-1
Fig. 3. Apoptotic (A) and dark (B) chondrocytes of the hypertrophic zone of the proximal femoral epiphysis from the 21-day-old rat fetus
and 7-day-old rat pup, respectively (TEM, original magnification ×3000).
On the other hand, parathyroid hormone related peptide
(PTHrP) is a potent inhibitor of apoptosis, through the
mechanism of up-regulation of the apoptosis inhibitor
Bcl-2. In addition to phosphate, adverse effects have
been seen by glucocorticoids and radiation, which
yields and increase in apoptosis [52-55]. In animals
treated with a ten-day course of glucocorticoids, an
increase of apoptosis in the hypertrophic chondrocytes
yields a growth plate with a reduced width was revealed
[53]. Both, PTHrH and parathyroid hormone are the
main stimulators of the perichondrium. The physiologi-
cal balance between both factors regulates chondrocytes
proliferation and differentiation. Maturation and termi-
nal differentiation also depends on the Indian Hedgehog
(Ihh) peptide, which regulates expression of genes
coded on the hedgehog receptor and transcriptional fac-
tor Gli1 [56,57]. Ihh synthesis begins throughout mes-
enchymal condensation, increases during cartilage for-
mation and later decreases. Without the factor, the peri-
chondrium transforms into periosteum [59]. Its overex-
pression up-regulates the expression of perichondrial
PTHrP, which keeps chondrocytes in the proliferating
state, and slows or even inhibits hypertrophy. Ihh regu-
lates the proportion of chondrocytes dividing and with-
drawing from the cell cycle through negative feedback
[60,61].
It should be noted, that the periarticular chondro-
cytes produce PTHrP, but its receptor is found particu-
larly in the prehypertrophic cells and the lower prolif-
erating zone. The mechanism of PTHrP activity is
achieved by delaying the hypertrophic differentiation
in the lower proliferating zone by maintaining cells in
the prehypertrophic phenotype. Secondary to activa-
tion of PTH/PTHrP receptors, PTHrP stimulates cell
proliferation by G protein activation and delays their
transformation into prehypertrophic and hypertrophic
chondrocytes. When proliferation is completed, chon-
drocytes release Ihh, which stimulates PTHrP synthe-
sis via a feedback loop [56,57].
Transgenic mice lacking PTHrP or its receptor have
shown signs of dwarfism caused by the accelerated
differentiation and premature hypertrophy. In contrast
overexpression of PTHrP causes slower cellular differ-
entiation and a secondary reduction of bone length
[61]. In humans, a mutated PTHrP and receptor results
in Jansen metaphyseal chondrodysplasia, a dwarfing
condition due to a postponement in growth plate min-
eralization and hypocalcaemia [62].
The next important biological system is related to the
thyroid hormone working with major regulatory path-
ways that govern the proliferation and differentiation of
chondrocytes and changes in the ECM [63,64]. Thyrox-
in stimulates type X collagen synthesis along with other
various maturational features through the introduction
of BMP-2 [65]. The expression of genes that code these
hormones is dependent upon the particular tissue and is
regulated at different stages of development. One of the
thyroid receptors, TRα1, is predominant in bone, heart,
and central nervous system [66]. Deletion of TRα iso-
form results in stunted linear bone growth, disorganized
columnar scaffold of growth plates, lagging cartilage
mineralization, and retarded chondrocyte hypertrophy.
On the other hand, the deletion of TRβ did not produce
any of these abnormalities [63].
When thyroid hormone is absent or inhibited, the
resulting clinical manifestation is hypothyroidism. Rel-
evant symptoms of hypothyroidism in skeletal system
include: decreased rate of bone formation, decreased
thickness of growth plates of long bones, disorganiza-
tion of the normal cartilage columns of the growth
plates, and hindered differentiation of growth plate
chondrocytes into hypertrophic cells [67]. Additionally,
it has been noted that the receptor proteins are expressed
in reserve and proliferating zone chondrocytes, but not
in hypertrophic one in rat growth plate [67]. However,
in humans, TRα1 is present in undifferentiated, prolif-
erating, mature and hypertrophic chondrocytes [68].
According to in vitro observations, triiodthyronine
(T3) stimulates growth and maturation of porcine
scapular and pelvic growth plate cartilage [70]. Its
enhancement also causes an increase in mRNA and
protein levels of type X collagen, cellular hypertrophy,
and alkaline phosphatase activity, which are all indica-
tors of terminally differentiated growth plate chondro-
cytes [33,34,64,69].
Thyroid hormone is also a modulator of other bio-
logical factors. Insulin-like growth facor-1 (IGF-1), for
example, is a downstream effector for growth hormone
that stimulates the local synthesis of IGF-1 and causes
an increase in the rate of cell division [70,71]. In addi-
tion, thyroid hormone may be able to act directly on
growth plate chondrocytes through growth hormone-
independent mechanisms [34,64]. Further, transgenic
mice deficient of the IGF-1 have growth retardation
with intense defects in skeleton and various internal
organs. This causes death within twenty-four hours
after birth [72]. In humans, however, the mutated IGF-1
causes Laron syndrome, characterized by hereditary
dwarfism resulting from low serum factor levels [73].
There is also an implication that thyroid hormone
could potentially be involved in regulating the set
point of the PTHrP-Ihh feedback loop [74]. The hor-
mone enhances FGF signaling that could regulate the
inhibitory effects of thyroid hormone on growth plate
cell proliferation [63,75].
The effects of thyroid hormone inhibitors have also
been studied. Peroxisome proliferator activated recep-
tors (PPARs) are negative regulators of thyroid hor-
mone signaling [76]. PPARγ and ciglitazone – one of
its ligands – inhibits thyroid hormone-induced increas-
es in alkaline phosphatase activity by increasing apop-
tosis. It is believed, that the receptor is one of the few
12 F. Burdan et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(1): 12 (5-16) 
doi: 10.2478/v10042-009-0007-1
negative regulators of thyroid hormone-mediated
skeletal growth and gene transcription [63].
It was also observed that thyroid hormone activates
Wnt/β-catenin signaling in chondrocytes of growth
plate. Wnt-4 activates β-catenin signaling and encour-
ages terminal differentiation. The main role of 
β-catenin is to stimulate differentiation of growth plate
chondrocytes and increase alkaline phosphatase activ-
ity [64]. When Wnt is inhibited, T3-induced terminal
differentiation is blocked and alkaline phosphatase
activity is decreased. Based on the above observations,
it seems that T3 stimulates growth plate chondrocyte
terminal differentiation by amplifying Wnt-4 expres-
sion, and increasing β-catenin, TCF/LEF transcription-
al activity, and expression of the Wnt/β-catenin target
gene Runx2/cbfal [64,77].
Iodothyronine deiodinase is another active hor-
mone in the growth plate. An insufficient expression
of iodothyronine deiodinase type 2 (DIO2) results in
tibial dyschondroplasia, the inability of chondrocytes
to undergo terminal differentiation [78]. When DIO2
is expressed via WSB-1 complex, PTHrP is also pre-
sented and chondrocyte differentiation is modulated
[63].
Furthermore, just as thyroid hormone is regulated,
apoptosis is monitored as well. There are many ways in
which apoptosis is monitored or regulated. One of the
ways, apoptosis in the growth plate is regulated by bal-
ancing the Bcl-2 protein and an apoptosis inhibitor Bax
[79]. If this balance is interrupted, growth plate function
is affected and the length of long bones is distorted. The
deletion of the Bcl-2 gene accelerates apoptosis of chon-
drocytes, and causes a decrease in thickness of the
growth plate and shortened long bones [80].
One of the most important components in activat-
ing apoptosis is the calcium and phosphate (Pi) ion
pair [81] that decreases the mitochondrial membrane
potential and initiates the process of apoptosis [52]. Pi
causes an increase of nitric oxide (NO). Inhibitors of
NO synthase and Pi transport cause a decrease in NO
concentration, thus preventing cell death [82]. In addi-
tion, NO production causes sheer stress, which reduces
the expression of type II collagen mRNA and aggrecan
[83]. Elevated levels of NO, its synthase (iNOS), and
nitrate have been linked to osteoarthritis. In addition,
iNOS is expressed when chondrocytes are exposed to
cytokines such as IL-1 and TNF-α. IL-1, which is acti-
vated by NO, and in turn can inhibit chondrocyte pro-
liferation by acting in conjunction with PGE2, a chon-
drocyte growth inhibitor [84].
There are two main ways that NO sensitizes chon-
drocytes to apoptosis: decreases the thiol reserve [86]
and affects the survival of the cell under oxidative or
nitrosative tension. Furthermore, NO decreases mito-
chondrial membrane potential, which causes a loss of
tight coupling, an essential prerequisite for generating
ATP by means of oxidative phosphorylation. Interfer-
ence with mitochondrial activity causes a loss of ATP
production leading to a low energy state, which makes
chondrocytes more susceptible to enter apoptosis [86].
NO also interferes with cellular adhesion to the extra-
cellular membrane. Chondrocytes depend on adhesion
due to survival signals are provided for them by the
membrane through matrix interactions and proteogly-
cans [87]. Similarly, β1-integrin-mediated cell matrix
interaction gives signals to chondrocytes for survival.
The loss of this interaction accompanied by the inca-
pability to respond to IGF-1 can cause osteoarthritis
via hypocellularity and matrix degradation [88].
Several other factors are associated with chondro-
genesis, i.a., TGFβ, heparan sulfate, fibroblast growth
factor receptor-3 (FGFR-3), pleiotrphin/midkine [59].
TGFβ is an influential inhibitor of maturation,
which includes cell hypertrophy, type-X collagen syn-
thesis, and alkaline phosphatase activity. The actions
are mediated by Smad-3, which is also a transcription
factor [89,90]. Studies have illustrated that Smad-3
deficient mice have a normal skeleton at birth, but at
three weeks of age, they show signs of cartilage abnor-
malities, which result in decreased longitudinal growth
[91]. PTHrP, Ihh and TGFβ seem to be the primary
regulators of cell proliferation in the growth plate, but
other factors such as FGFR-3 also play an important
roles [92,93]. A mutation in the gene coding the recep-
tor protein results in achondroplasia, which is a dwarf-
ing condition caused by the reduction of proliferation
in the growth plate [94].
Heparan sulfate (HSPG) in mouse cartilage is
found mainly in proliferating, differentiating, and pre-
hypertrophic chondrocytes, but is reduced in terminal-
ly differentiated hypertrophic chondrocytes. Further-
more, HIP/RPL29, a heparan sulfate gene, is up-regu-
lated in carcinomas. Fibronectins are thought to be
involved with HSPGs and cartilage integrin α5β1,
influencing cellular morphology [59]. At the moment,
there is inadequate evidence regarding the expression
of HSPG remodeling enzymes in developing and
mature cartilage. However, heparan sulfate is needed
for the morphogenesis of individual organs and carti-
lage formation, which is necessary for skeletal struc-
ture [95,96].
Conclusion
The cartilage growth plate is a highly specialized
skeletal structure, essential for bone growth and devel-
opment. Its formation is a final step of chondrogenesis
and is regulated by various factors that modulate cel-
lular proliferation and terminal differentiation, allow-
ing the transformation to apoptotic and autophagal
bodies, paralysis, and dark chondrocytes. There is also
another highly unknown transdifferentation process in
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which chondrocytes transform into osseous cells. All
these mechanisms lead to bone growth and elongation.
It is estimated that 60% of the bone growth is due to
chondrocyte hypertrophy, 10% to cell proliferation and
the remainder to matrix synthesis.
Any disturbance of the plate physiology cause
developmental abnormalities. For example, the final
manifestation of mutations in genes coding specific
types of collagen is: Stickler syndrome (collagen type
XI), Schmid metaphyseal chondrodysplasia (collagen
type X) or spondyloepiphyseal and Kniest dysplasia
(collagen type II) [97,98,99]. Furthermore, abnormali-
ties in IGF1, hedgehog pathway PTHrP and, as well as
other important differentiation factors, may induce
changes that manifest as dwarfism [100,101]. Various
pathological factors are also known, while the etiology
of other serious growth plate diseases is still unidenti-
fied. Intensifications of basic studies will provide
prospects for new physiological pathways of the chon-
drocyte cell cycle and will be helpful in evaluating of
such illnesses and their treatments in the future.
References
[ 1] Melrose J, Smith SM, Smith MM, Little CB. The use of His-
tochoice for histological examination of articular and growth
plate cartilages, intervertebral disc and meniscus. Biotech
Histochem. 2008;83:47-53.
[ 2] Provot S, Schipani E. Fetal growth plate: a developmental
model of cellular adaptation to hypoxia. Ann NY Acad Sci.
2007;1117:26-39.
[ 3] Mau E, Whetstone H, Yu C, Hopyan S, Wunder JS, Alman
BA. PTHrP regulates growth plate chondrocyte differentia-
tion and proliferation in a Gli3 dependent manner utilizing
hedgehog ligand dependent and independent mechanisms.
Dev Biol. 2007;305:28-39.
[ 4] Erenpresia J, Roach HI. Aberrations of cell cycle and cell
death in normal development of the chick embryo growth
plate. Mech Ageing Dev. 1999;108:227-338.
[ 5] DeLise AM, Fischer L, Tuan RS. Cellular interactions and
signaling in cartilage development. Osteoarthritis Cartilage.
2000;8:309-334.
[ 6] Wezeman FH. Morphological foundations of precartilage
development in mesenchyme. Microsc Res Tech. 1998;43:91-
101.
[ 7] Haas AR, Tuan RS. Chondrogenic differentiation of murine
C3H10T1/2 multipotential mesenchymal cells: II. Stimula-
tion by bone morphogenetic protein-2 requires modulation of
N-cadherin expression and function. Differentiation. 1999;64:
77-89.
[ 8] Chimal-Monroy J, Díaz de León L. Expression of N-cadherin,
N-CAM, fibronectin and tenascin is stimulated by TGF-
beta1, beta2, beta3 and beta5 during the formation of precar-
tilage condensations. Int J Dev Biol. 1999;43:59-67.
[ 9] Baserga R, Rubin R. Cell cycle and growth control. Crit Rev
Eukaryot Gene Expr. 1993;3:47-61.
[10] Huang W, Zhou X, Lefebvre V, de Crombrugghe B. Phospho-
rylation of SOX9 by cyclic AMP-dependent protein kinase A
enhances SOX9's ability to transactivate a Col2a1 chondro-
cyte-specific enhancer. Mol Cell Biol. 2000;20:4149-4158.
[11] Zhang P, Jimenez SA, Stokes DG. Regulation of human
COL9A1 gene expression. Activation of the proximal pro-
moter region by SOX9. J Biol Chem. 2003;278:117-123.
[12] Akiyama H, Chaboissier MC, Martin JF, et al. The transcrip-
tion factor Sox9 has essential roles in successive steps of the
chondrocytes differentiation pathway and is required for
expression of Sox5 and Sox 6. Genes Dev. 2002;16:2813-
2828.
[13] Eames BF, de la Fuente L, Helms JA. Molecular ontogeny of
the skeleton. Birth Defects Res C Embryo Today. 2003;69:93-
101.
[14] Lefebvre V, Smits P. Transcriptional control of chondrocyte
fate and differentiation. Birth Defects Res C Embryo Today.
2005;75:200-212.
[15] Zhao Q, Eberspaecher H, Lefebvre V, de Crombrugghe B.
Parallel expression of Sox9 and Col2a1 in cells undergoing
chondrogenesis. Dev Dyn 1997;209:377-386.
[16] Abad V, Meyers JL, Weise M, et al. The role of the resting
zone in growth plate chondrogenesis. Endocrinology.
2002;143:1851-1857. 
[17] Johnstone EW, Leane PB, Kolesik P, Byers S, Foster BK.
Spatial arrangement of physeal cartlage chondrocytes and the
structure of the primary spongiosa. J Orthop Sci. 2000;5:294-
301.
[18] Burdan F, Szumilo J, Marzec B, Klepacz R, Dudka J. Skele-
tal developmental effects of selective and nonselective
cyclooxygenase-2 inhibitors administered through organo-
genesis and fetogenesis in Wistar CRL:(WI)WUBR rats. Tox-
icology. 2005;216:204-223.
[19] Grimsrud CD, Romano PR, D'Souza M, et al. BMP-6 is an
autocrine stimulator of chondrocyte differentiation. J Bone
Miner Res. 1999;14:475-482.
[20] Kirsch T, Harrison G, Golub EE, Nah HD. The roles of annex-
ins and type II an X collagen in matrix vesicle-mediated min-
eralization of growth plate cartilage. J Biol Chem. 2000;275:
35577-35583.
[21] Alvarez J, Balbin M, Fernandez M, Lopez JM. Collagen
metabolism is markedly altered in the hypertrophic cartilage
of growth plates from rats with growth impairment second-
ary to chronic renal failure. J Bone Miner Res. 2001;16:511-
524.
[22] Ballock RT, O'Keefe RJ. Current concepts review: The biolo-
gy of the growth plate. J Bone Joint Surg. 2003;85A:715-726.
[23] Smits P, Dy P, Mitra S, Lefebvre V. Sox5 and Sox6 are need-
ed to develop and maintain source, columnar, and hyper-
trophic chondrocytes in the cartilage growth plate. J Cell Biol.
2004;747-758.
[24] Yoshida CA, Yamamoto H, Fujita T, et al. Runx2 and Runx3
are essential for chondrocytes maturation, and Runx2 regu-
lates limb growth through induction of Indian hedgehog.
Genes Dev. 2004;18:952-963.
[25] Takeda S, Bonnamy JP, Owen MJ, et al. Continuous expres-
sion of Cbfa1 in nonhypertrophic chondrocytes uncovers its
ability to induce hypertrophic chondrocyte differentiation and
partially rescues Cbfa1-deficient mice. Genes Dev. 2001;15:
467-481.
[26] Hunziker EB. Mechanism of longitudinal bone growth and its
regulation by growth plate chondrocytes. Microsc Res Tech.
1994;28:505-519.
[27] Farnum CE, Wilsman NJ. Converting a differentiation cas-
cade into longitudinal growth: stereology and analysis of
transgenic animals as tools for understanding growth plate
function. Curr Opin Orthop. 2001;12:428-433.
[28] Kim IS, Otto F, Zabel B, Mundlos S. Regulation of chondro-
cyte differentiation by Cbfa1. Mech Dev. 1999;80:159-170.
[29] Leboy P, Grasso-Knight G, D'Angelo M, et al. Smad-Runx
interactions during chondrocyte maturation. J Bone Joint
Surg Am. 2001;83 Suppl 1:S15-22.
[30] Aharinejad S, Marks SC Jr, Bock P, et al. Microvascular pat-
tern in the metaphysic during bone growth. Anat Rec. 1995;
242:111-122.
14 F. Burdan et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(1): 14 (5-16) 
doi: 10.2478/v10042-009-0007-1
[31] Skawina A, Litwin JA, Gorczyca J, Miodonski AJ. The vascular
system of human fetal long bones: a scanning electron micro-
scope study of corrosion casts. J Anat. 1994;185:369-376.
[32] Roach HI, Baker JE, Clarke NM. Initiation of the bony epi-
physis in long bones: chronology of interactions between the
vascular system and the chondrocytes. J Bone Miner Res.
1998;13:950-961.
[33] Ahmed YA, Tatarczuch L, Pagel CN, Davies HM, Mirams M,
Mackie EJ. Physiological death of hypertrophic chondro-
cytes. Osteoarthritis Cartilage. 2007;15:575-586.
[34] Solomon LA, Bérubé NG, Beier F. Transcriptional regulators
of chondrocyte hypertrophy. Birth Defects Res C Embryo
Today. 2008;84:123-130.
[35] Pucci B, Adams CS, Fertala J, et al. Development of the ter-
minally differentiated state sensitizes epiphyseal chondro-
cytes to apoptosis through caspase-3 activation. J Cell Physi-
ol. 2007;210:609-615.
[36] Cummings MC, Winterford CM, Walker NI. Apoptosis. Am J
Surg Pathol. 1997;21:88-101.
[37] Roach HI, Aigner T, Kouri JB. Chondroptosis: a variant of
apoptotic cell death in chondrocytes? Apoptosis. 2004;9:265-
277.
[38] Erenpreisa J, Roach HI. Aberrant death in dark chondrocytes
of the avian growth plate. Cell Death Differ. 1998;5:60-66.
[39] Roach HI, Erenpreisa J. The phenotypic switch from chon-
drocytes to bone-forming cells involves asymmetric cell divi-
sion and apoptosis. Connect Tissue Res. 1996;35:85-91.
[40] Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in meta-
zoans: cell survival in the land of plenty. Nat Rev Mol Cell
Biol. 2005;6:439-448.
[41] Lum JJ, Bauer DE, Kong M, et al. Growth factor regultion of
autophagy and cell survival in the absence of apoptosis. Cell.
2005;120:237-248.
[42] Phornphutkul C, Wu KY, Auyeung V, Chen Q, Gruppuso PA.
mTOR signaling contributes to chondrocyte differentiation.
Dev Dyn. 2008;237:702-712.
[43] Roach HI, Clarke NM. Physiological cell death of chondro-
cytes in vivo is not confined to apoptosis. New observations
on the mammalian growth plate. J Bone Joint Surg Br. 2000;
82:601-613.
[44] Roach HI, Clarke NM. "Cell paralysis" as an intermediate
stage in the programmed cell death of epiphyseal chondro-
cytes during development. J Bone Miner Res. 1999;14:1367-
1378.
[45] Ghadially FN. The dark-light cell phenomenon. In:
Ultrastructural pathology of the cell and matrix. New York,
Butterworth-Heinemann: 1997:954-961.
[46] Hwang WS. Ultrastructure of human foetal and neonatal hya-
line cartilage. J Pathol. 1978;126:209-214.
[47] Silbermann M, Frommer J. Heterogeneity among chondro-
cytes of the mandibular condyle in foetal and postnatal mice.
Arch Oral Biol. 1973;18:1549-1554.
[48] Wilsman NJ, Farnum CE, Hilley HD, Carlson CS. Ultrastruc-
tural evidence of a functional heterogeneity among physeal
chondrocytes in growing swine. Am J Vet Res. 1981;42:1547-
1553.
[49] Solecki M. Evaluation of TNF gene expression and morphol-
ogy of epiphyseal cartilage in rat offsprings exposed to
cyclooxygenase inhibitors (PhD Thesis) Lublin: Medical
University of Lublin; 2007.
[50] Mansfield K, Rajpurohit R, Shapiro IM. Extracellular phos-
phate ions cause apoptosis of terminally differentiated epi-
physeal chondrocytes. J Cell Physiol. 1999;179:279-86
[51] Rajpurohit R, Mansfield K, Ohyama K, Ewert D, Shapiro IM.
Chondrocyte death is linked to development of a mitochondr-
ial membrane permeability transition in the growth plate. 
J Cell Physiol. 1999;179:287-96
[52] Silvestrini G, Ballanti P, Patacchioll FR, et al. Evaluation of
apoptosis and the glucocorticoid receptor in the cartilage
growth plate and metaphyseal bone cells of rats after high
dose treatment with corticosterone. Bone. 2000;26:33-42.
[53] Pateder DB, Eliseev RA, O'Keefe RJ, et al. The role of
autocrine growth factors in radiation damage to the epiphy-
seal growth plate. Radiat Res. 2001;155:847-857.
[54] Hilton MJ, Tu X, Long F. Tamoxifen-inducible gene deletion
reveals a distinct cell type associated with trabecular bone,
and direct regulation of PTHrP expression and chondrocyte
morphology by Ihh in growth region cartilage. Dev Biol.
2007;308:93-105.
[55] St-Jacques B, Hammerschmidt M, McMahon AP. Indian
hedgehog signaling regulates proliferation and differentiation
of chondrocytes and is essential for bone formation. Genes
Dev. 1999;13:2072-286.
[56] Sakamoto A, Chen M, Nakamura T, Xie T, Karsenty G, Wein-
stein LS. Deficiency of the G-protein alpha-subunit G(s)alpha
in osteoblasts leads to differential effects on trabecular and
cortical bone. J Biol Chem. 2005;280:21369-21375.
[57] Sakamoto A, Chen M, Kobayashi T, Kronenberg HM, Wein-
stein LS. Chondrocyte-specific knockout of the G protein
G(s)alpha leads to epiphyseal and growth plate abnormalities
and ectopic chondrocyte formation. J Bone Miner Res. 2005;
20:663-671.
[58] Chung UI, Schipani E, McMahon AP, Kronenberg HM. Indi-
an hedgehog couples chondrogenesis to osteogenesis in endo-
chondral bone development. J Clin Invest. 2001;107:295-304.
[59] Kirn-Safran CB, Gomes RR, Brown AJ, Carson DD. Heparan
sulfate proteoglycans: coordinators of multiple signaling
pathways during chondrogenesis. Birth Defects Res C
Embryo Today. 2004;72:69-88.
[60] Lai LP, Mitchell J. Beta2-adrenergic receptors expressed on
murine chondrocytes stimulate cellular growth and inhibit the
expression of Indian hedgehog and collagen type X. J Cell
Biochem. 2008;104:545-553.
[61] Schipani E, Lanske B, Hunzelman J, et al. Targeted expres-
sion of constitutively active receptors for parathyroid hor-
mone and parathyroid hormone-related peptide delays endo-
chondral bone formation and rescues mice that lack parathy-
roid hormone related peptide. Proc Natl Acad Sci USA. 1997;
94:13689-13694.
[62] Schipani E, Langman CB, Parfitt AM, et al. Constitutively
activated receptors for parathyroid hormone and parathyroid
hormone-related peptide in Jansen's metaphyseal chon-
drodysplasia. N Engl J Med. 1996;335:708-714.
[63] Shao YY, Wang L, Ballock RT. Thyroid hormone and the
growth plate. Rev Endocr Metab Disord. 2006;7:265-271.
[64] Wang L, Shao YY, Ballock RT. Thyroid hormone interacts
with the Wnt/beta-catenin signaling pathway in the terminal
differentiation of growth plate chondrocytes. J Bone Miner
Res. 2007;22:1988-1995.
[65] Ballock RT, Mink LM, Chen DH, Mita BC. Thyroid hormone
regulates terminal differentiation of growth plate chondro-
cytes through local induction of bone morphogenic proteins.
Trans Orthop Res Soc. 2000;25:160.
[66] Van Vliet G, Larroque B, Bubuteishvili L, Supernant K, Leger
J. Sex-specific impact of congenital hypothyroidism due to
thyroid dysgenesis on skeletal maturation in term newborns.
J Clin Endocrinol Metab. 2003;88:2009-2013.
[67] Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet
SM, Willaims GR. Thyroid hormones regulate hypertrophic
chondrocyte differentiation and expression of parathyroid
hormone-related peptide and its receptor during endochon-
dral bone formation. J Bone Miner Res. 2000;15:2431-
2442.
[68] Abu EO, Horner A, Teti A, Chatterjee VK, Compston JE. The
localization of thyroid hormone receptors mRNAs in human
bone. Thyroid. 2000;10:287-293.
15Epiphyseal growth plate
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(1): 15 (5-16) 
doi: 10.2478/v10042-009-0007-1
[69] Burch WM, Van Wyk JJ. Triiodothyronine stimulates carti-
lage growth and maturation by different mechanisms. Am J
Physiol. 1987;252:E176-182.
[70] Ohlsson C, Isgaard J, Tornell J, Nilsson A, Isaksson OG, Lin-
dahl A. Endocrine regulation of longitudinal bone growth.
Acta Paediatr. 1993;391 Suppl 92:33-41.
[71] Wang Y, Nishida S, Sakata T, et al. Insulin-like growth factor-
I is essential for embryonic bone development. Endocrinolo-
gy. 2006;147:4753-4761.
[72] Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A.
Mice carrying null mutations of the genes encoding insulin-
like growth factor I (Igf-1) and type 1 IGF receptor (IGF1r).
Cell. 1993;75:59-72.
[73] Uckun-Kitapci A, Haqq AM, Purnell JQ, Newcomb K,
Gulkesen H, Underwood LE. Serum ghrelin concentrations
are increased in children with growth hormone insensitivity
and decrease during long-term insulinlike growth factor-I
treatment. J Investig Med. 2008;56:26-31.
[74] Vortkamp A, Lee K, Lanske B, Segre GV, Kroneberg HM,
Tabin CJ. Regulation of rate of cartilage differentiation by
Indian hedgehog and PTH-related protein. Science. 1996;273:
613-622.
[75] Krejci P, Krakow D, Mekikian PB, Wilcox WR. Fibroblast
growth factors 1, 2, 17, and 19 are the predominant FGF lig-
ands expressed in human fetal growth plate cartilage. Pediatr
Res. 2007;61:267-272.
[76] Araki O, Ying H, Furuya F, Zhu X, Cheng SY. Thyroid hor-
mone receptor beta mutants: dominant negative regulators of
peroxisome proliferators-activated receptor gamma action.
Proc Natl Acad Sci U S A. 2005;102:16251-16256.
[77] Andrade AC, Nilsson O, Barnes KM, Baron J. Wnt gene
expression in the post-natal growth plate: regulation with
chondrocyte differentiation. Bone. 2007;40:1361-1369.
[78] Shen S, Berry W, Jaques S, Pillai S, Zhu J. Differential
expression of iodothyronine deiodinase type 2 in growth
plates of chickens divergently selected for incidence of tibial
dyschondroplasia. Anim Genet. 2004;35:114-118.
[79] Wang Y. Toury R, Hauchecorne M, Blamain N. Expression of
Bcl-2 protein in the epiphyseal plate cartilage and trabecular
bone of growing rats. Histochem Cell Biol. 1997;108:45-55. 
[80] Amling M, Neff L, Tanaka S, et. al. Bcl-2 lies downstream of
parathyroid hormone-related peptide in signaling pathway
that regulates chondrocyte maturation during skeletal devel-
opment. J Cell Biol. 1997;136:205-213.
[81] Magne D, Bluteau G, Faucheux C, et al. Phosphate is a spe-
cific signal for ATDC5 chondrocyte maturation and apopto-
sis-associated mineralization: possible implication of apopto-
sis in the regulation of endochondral ossification. J Bone
Miner Res. 2003;18:1430-1442.
[82] Teixeira CC, Ischiropoulos H, Leboy P, et al. Nitric oxide-
nitric oxide synthase regulates key maturational events during
chondrocyte terminal differentiation. Bone. 2005;37:37-45.
[83] Lee MS, Trindade MCD, Ikenoue T, Schurman DJ, Goodman
SB, Smith RL. Effects of shear stress on nitric oxide and
matrix protein gene expression in human osteoarthritic chon-
drocytes in vitro. J Orthop Res. 2002;20:556.
[84] Blanco FJ, Oschs RL, Schwar H, Lotz M. Chondrocyte apop-
tosis induced by nitric oxide. Am J Pathol. 1995;146:75-85.
[85] Teixeira CC, Rajpurohit R, Mansfield K, et al. Maturation-
dependent thiol loss increases chondrocyte susceptibility to
apoptosis. J Bone Miner Res. 2003;18:662-668.
[86] Teixeira CC, Mansfield K, Hertkorn C, et al. Phosphate
induced chondrocyte apoptosis is linked to nitric oxide gener-
ation. Am J Physiol Cell Physiol. 2001;281:C833-C839.
[87] Cao L, Lee V, Adams ME, Kiani C, Zhang YO, Hu W, Yang
BB. β1-Integrin-collagen interaction reduces chondrocyte
apoptosis. Matrix Biol. 1999;18:343-355.
[88] Mobasheri A, Carter SD, Martin-Vasallo M, Shakibaei M.
Integrins and stretch activated ion channels; putative com-
ponents of functional cell surface mechanoreceptors in artic-
ular chondrocytes. Cell Biol Int. 2002;26:1-18.
[89] Ferguson CM, Schwarz EM, Reynolds PR, Puzas JE, Rosier
RN, O'Keefe RJ. Smad2 and 3 mediate transforming growth
factor-beta1 induced inhibition of chondrocyte maturation.
Endocrinology. 2000;141:4728-4735.
[90] Pateder DB, Ferguson CM, Ionescu AM, et al. PTHrP
expression in chick sterna chondrocytes is regulated by
TGF-beta through Smad-mediated signaling. J Cell Physiol.
2001;188: 343-351.
[91] Pedrozo HA, Schwartz Z, Gomez R, et al. Growth plate
chondrocytes store latent transforming factor (TGF)-beta 1
in their matrix through latent TGF-beta 1 binding protein-1.
J Cell Physiol. 1998;177:343-354.
[92] Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitiz
DM. Skeletal over-growth and deafness in mice lacking
fibroblast growth factor receptor 3. Nat Genet. 1996;12:390-
397.
[93] Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibrob-
last growth factor receptor 3 is a negative regulator of bone
growth. Cell. 1996;84:911-921.
[94] Vajo Z, Francomano CA, Wilkin DJ. The molecular and
genetic basis of fibroblast growth factor receptor 3 disorders:
the achondroplasia family of skeletal dysplasias, Muenke
craniosynostosis, and Crouzon syndrome with acanthosis
nigricans. Endocr Rev. 2000;21:23-39.
[95] Perrimon N, Bernfield M. Specificities of heparan sulphate
proteoglycans in developmental processes. Nature. 2000;
404:725-728.
[96] Princivalle M, de Agostini A. Developmental roles of
heparan sulfate proteoglycans: a comparative review in
Drosophilia, mouse and human. Int J Dev Biol. 2002;46:
267-278.
[97] Horton WA, Hecht JT. The chondrodysplasias. In: Royce
PM, Steinmann B, eds. Connective tissue and its heritable
disorders: molecular, genetic, and medical aspects. New
York, Wiley-Liss; 1993:641-675.
[98] Holden P, Canty EG, Mortier GR, et al. Identification of
novel pro-alpha2(IX) collagen gene mutations in two fami-
lies with distinctive oligo-epiphyseal forms of multiple epi-
physeal dysplasia. Am J Hum Genet. 1999;65:31-38.
[99] Sirko-Osadsa DA, Murray MA, Scott JA, Lavery MA, War-
man ML, Robin NH. Stickler syndrome without eye
involvement is caused by mutations in COL11A2, the gene
encoding the alpha2(XI) chain type XI collagen. J Pediatr.
1998;132:368-371.
[100] Kimura H, Ng JM, Curran T. Transient inhibition of the
Hedgehog pathway in young mice causes permanent defects
in bone structure. Cancer Cell. 2008 Mar;13(3):249-260.
[101] Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS,
Alanay Y. The skeletal dysplasias: clinical-molecular corre-
lations. Ann NY Acad Sci. 2007;1117:302-309.
Submitted: 14 October, 2008
Accepted after reviews: 4 December, 2008
16 F. Burdan et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(1): 16 (5-16) 
doi: 10.2478/v10042-009-0007-1
